vs
Amarin Corp plc（AMRN）与CENTERSPACE（CSR）财务数据对比。点击上方公司名可切换其他公司
CENTERSPACE的季度营收约是Amarin Corp plc的1.5倍（$66.6M vs $45.1M），Amarin Corp plc净利率更高（-23.3% vs -27.7%，领先4.4%），Amarin Corp plc同比增速更快（7.0% vs 0.3%），过去两年CENTERSPACE的营收复合增速更高（1.6% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Centerspace是一家专注于多户住宅物业持有、运营与开发的房地产投资企业，核心业务覆盖美国中西部及落基山西部区域，面向不同租户群体提供经济型及高端住宅选择，重视租户体验与资产长期价值增长。
AMRN vs CSR — 直观对比
营收规模更大
CSR
是对方的1.5倍
$45.1M
营收增速更快
AMRN
高出6.7%
0.3%
净利率更高
AMRN
高出4.4%
-27.7%
两年增速更快
CSR
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $66.6M |
| 净利润 | $-10.5M | $-18.4M |
| 毛利率 | — | 96.5% |
| 营业利润率 | 35.5% | -15.9% |
| 净利率 | -23.3% | -27.7% |
| 营收同比 | 7.0% | 0.3% |
| 净利润同比 | 33.0% | -262.9% |
| 每股收益（稀释后） | — | $-1.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNCSR
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $66.6M | ||
| Q3 25 | $49.7M | $71.4M | ||
| Q2 25 | $72.7M | $68.5M | ||
| Q1 25 | $42.0M | $67.1M | ||
| Q4 24 | $62.3M | $66.4M | ||
| Q3 24 | $42.3M | $65.0M | ||
| Q2 24 | $67.5M | $65.0M |
净利润AMRNCSR
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-18.4M | ||
| Q3 25 | $-7.7M | $53.8M | ||
| Q2 25 | $-14.1M | $-14.5M | ||
| Q1 25 | $-15.7M | $-3.7M | ||
| Q4 24 | $-48.6M | $-5.1M | ||
| Q3 24 | $-25.1M | $-1.0M | ||
| Q2 24 | $1.5M | $-1.3M |
毛利率AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 96.5% | ||
| Q3 25 | 44.7% | 96.5% | ||
| Q2 25 | 69.2% | 96.5% | ||
| Q1 25 | 59.8% | 96.4% | ||
| Q4 24 | -15.4% | 96.5% | ||
| Q3 24 | 38.5% | 96.6% | ||
| Q2 24 | 63.4% | 96.6% |
营业利润率AMRNCSR
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | -15.9% | ||
| Q3 25 | -22.4% | — | ||
| Q2 25 | -22.0% | -9.9% | ||
| Q1 25 | -39.9% | 7.1% | ||
| Q4 24 | -84.3% | 4.3% | ||
| Q3 24 | -59.5% | 9.8% | ||
| Q2 24 | -0.8% | 11.1% |
净利率AMRNCSR
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -27.7% | ||
| Q3 25 | -15.6% | 75.3% | ||
| Q2 25 | -19.4% | -21.2% | ||
| Q1 25 | -37.4% | -5.6% | ||
| Q4 24 | -78.0% | -7.6% | ||
| Q3 24 | -59.4% | -1.6% | ||
| Q2 24 | 2.3% | -2.0% |
每股收益（稀释后）AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-1.08 | ||
| Q3 25 | $-0.02 | $3.19 | ||
| Q2 25 | $-0.03 | $-0.87 | ||
| Q1 25 | $-0.04 | $-0.22 | ||
| Q4 24 | $-0.12 | $-0.31 | ||
| Q3 24 | $-0.06 | $-0.40 | ||
| Q2 24 | $0.00 | $-0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $12.8M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | — | $719.2M |
| 总资产 | $645.8M | $1.9B |
| 负债/权益比越低杠杆越低 | — | 1.42× |
8季度趋势，按日历期对齐
现金及短期投资AMRNCSR
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $12.8M | ||
| Q3 25 | $286.6M | $12.9M | ||
| Q2 25 | $298.7M | $12.4M | ||
| Q1 25 | $281.8M | $11.9M | ||
| Q4 24 | $294.2M | $12.0M | ||
| Q3 24 | $305.7M | $14.5M | ||
| Q2 24 | $306.7M | $14.3M |
总债务AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $955.5M | ||
| Q4 24 | — | $955.4M | ||
| Q3 24 | — | $921.3M | ||
| Q2 24 | — | $931.7M |
股东权益AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $719.2M | ||
| Q3 25 | $458.9M | $748.6M | ||
| Q2 25 | $464.9M | $710.1M | ||
| Q1 25 | $473.7M | $636.8M | ||
| Q4 24 | $486.2M | $752.0M | ||
| Q3 24 | $531.4M | $672.5M | ||
| Q2 24 | $551.9M | $680.7M |
总资产AMRNCSR
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $1.9B | ||
| Q3 25 | $659.8M | $2.1B | ||
| Q2 25 | $670.1M | $2.0B | ||
| Q1 25 | $655.7M | $1.9B | ||
| Q4 24 | $685.3M | $1.9B | ||
| Q3 24 | $750.6M | $1.9B | ||
| Q2 24 | $799.9M | $1.9B |
负债/权益比AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | — | 1.42× | ||
| Q3 25 | — | 1.53× | ||
| Q2 25 | — | 1.57× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | — | 1.37× | ||
| Q2 24 | — | 1.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $98.5M |
| 自由现金流经营现金流 - 资本支出 | — | $64.3M |
| 自由现金流率自由现金流/营收 | — | 96.5% |
| 资本支出强度资本支出/营收 | — | 51.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $125.9M |
8季度趋势，按日历期对齐
经营现金流AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $98.5M | ||
| Q3 25 | $-12.7M | $35.1M | ||
| Q2 25 | $16.6M | $25.3M | ||
| Q1 25 | $-12.5M | $25.4M | ||
| Q4 24 | $-13.3M | $98.2M | ||
| Q3 24 | $-2.4M | $32.3M | ||
| Q2 24 | $-2.7M | $22.9M |
自由现金流AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | — | $64.3M | ||
| Q3 25 | — | $25.7M | ||
| Q2 25 | — | $15.5M | ||
| Q1 25 | — | $20.4M | ||
| Q4 24 | — | $41.6M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $9.1M |
自由现金流率AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | — | 96.5% | ||
| Q3 25 | — | 36.0% | ||
| Q2 25 | — | 22.7% | ||
| Q1 25 | — | 30.4% | ||
| Q4 24 | — | 62.6% | ||
| Q3 24 | — | 31.5% | ||
| Q2 24 | — | 14.0% |
资本支出强度AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | — | 51.3% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | 7.5% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 18.2% | ||
| Q2 24 | — | 21.2% |
现金转化率AMRNCSR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
CSR
| Multi Family Residential | $57.3M | 86% |
| Other | $8.1M | 12% |
| Other Property Revenue | $1.2M | 2% |
